Keyphrases
Immunohistochemistry
100%
Estrogen Receptor
100%
Potential Biomarkers
100%
Cervical Carcinoma
100%
Fibroblast Activation Protein
100%
Human Epidermal Growth Factor Receptor 2 (HER2)
60%
Receptor Activation
60%
Treatment-naïve
60%
Tumor
40%
Clinical Outcomes
40%
Fluorescence in Situ Hybridization
40%
Protein Expression
40%
HER2 Amplification
40%
Tissue Microarray
20%
Tumor Stroma
20%
Targeted Therapy
20%
Squamous Cell Carcinoma (SqCC)
20%
Cancer Mortality
20%
Expression Pattern
20%
Cervical Cancer
20%
Prognostic Significance
20%
Distant Recurrence
20%
Potential Therapeutics
20%
Patient Samples
20%
Theranostics
20%
Pelvic Recurrence
20%
HER2 Overexpression
20%
Immunohistochemical Markers
20%
Targeted Imaging
20%
Immunohistochemical Expression
20%
Definitive Chemoradiation Therapy
20%
Antibody Therapy
20%
Non-squamous Cell Carcinoma
20%
Genitourinary Carcinomas
20%
Gynecologic Carcinoma
20%
Medicine and Dentistry
Biological Marker
100%
Immunohistochemistry
100%
Fibroblast
100%
Estrogen Receptor
100%
Uterine Cervix Carcinoma
100%
Neoplasm
60%
Recurrent Disease
60%
Fluorescence in Situ Hybridization
40%
Protein Expression
40%
Chemoradiation Therapy
20%
Tissue Microarray
20%
Stroma
20%
Cancer Mortality
20%
Targeted Therapy
20%
Squamous Cell Carcinoma
20%
Pelvis
20%
Cervical Cancer
20%
Female Genital Tract Cancer
20%
Antibody Therapy
20%
Carcinoma Cell
20%
Urogenital Tract Carcinoma
20%